The Patent Finder

Ambryx Biotechnology, Inc.

Also on record
Records under this name other than patents Ambryx Biotechnology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Ambryx Biotechnology, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,528,108Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
Lapsed on the fee record
Ended May 5, 2021 · USPTO record
Lapsed on the fee recordEnded May 5, 2021USPTO record
US 6,258,779Method of using fetuin to induce apoptosis in cancer cells
Term ended
Term ended Oct 7, 2019 · USPTO record
Term endedTerm ended Oct 7, 2019USPTO record
US 7,445,784Polypeptide for the treatment of cancer and a method for preparation thereof
Lapsed on the fee record
Ended Nov 4, 2016 · USPTO record
Lapsed on the fee recordEnded Nov 4, 2016USPTO record
US 8,247,380Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
Lapsed on the fee record
Ended Aug 21, 2016 · USPTO record
Lapsed on the fee recordEnded Aug 21, 2016USPTO record
US 6,737,402Method of preparing fetuin to induce apoptosis
Lapsed on the fee record
Ended May 18, 2016 · USPTO record
Lapsed on the fee recordEnded May 18, 2016USPTO record
US 6,720,311Polypeptide for the treatment of cancer and a method for preparation thereof
Lapsed on the fee record
Ended Apr 13, 2016 · USPTO record
Lapsed on the fee recordEnded Apr 13, 2016USPTO record
US 7,344,721Polypeptide for the treatment of cancer and a method for preparation thereof
Lapsed on the fee record
Ended Mar 18, 2016 · USPTO record
Lapsed on the fee recordEnded Mar 18, 2016USPTO record
US 7,341,724Polypeptide for the treatment of cancer and a method for preparation thereof
Lapsed on the fee record
Ended Mar 11, 2016 · USPTO record
Lapsed on the fee recordEnded Mar 11, 2016USPTO record
US 7,238,662Alpha 2HS glycoprotein for treatment of cancer and a method for preparation thereof
Lapsed on the fee record
Ended Jul 3, 2015 · USPTO record
Lapsed on the fee recordEnded Jul 3, 2015USPTO record
US 7,193,040Polypeptide for the treatment of cancer and a method for preparation thereof
Lapsed on the fee record
Ended Mar 20, 2015 · USPTO record
Lapsed on the fee recordEnded Mar 20, 2015USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited